EUVIMEDScopri EUVIMED
ÜbersichtsarbeitOpen access

Regulating arachidonic acid metabolism: a novel strategy to prevent colorectal inflammatory cancer transformation

Sisi Ren, Lu Lu, Hang Su, Zongping Li, Sumei Li, Jiashu Pan, Yujing Liu, Guang Ji, Hanchen Xu

Journal of Cancer · 2025-10-01 · 16 (14) · 4155-4171

DOI: 10.7150/jca.118694 ↗

At a glance

Übersichtsarbeit in Journal of Cancer, published on 2025-10-01. Written by Sisi Ren and 8 co-authors. Institution: Institute of Digestive Diseases, Longhua Hospital, China-Canada Center of Research for Digestive Diseases (ccCRDD), Shanghai University of Traditiona…. Cited 9 times so far (Crossref). The full text is freely available in PubMed Central.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Colorectal cancer (CRC) ranks among the leading causes of cancer-related morbidity and mortality worldwide, with colitis-associated colorectal cancer (CAC) driven by inflammatory cancer transformation. Arachidonic acid (AA), a key ω-6 polyunsaturated fatty acid, and its metabolites, including prostaglandins (PGs) and leukotrienes (LTs), play pivotal roles in this process by modulating inflammation, immune responses, and the intestinal microenvironment. Notably, a multi-enzyme co-expression nanoplatform integrating lipoxygenase (LOX) and phospholipase A2 (PLA2) has been developed, synergistically inducing immunogenic ferroptosis and upregulating AA expression to enhance CD8+ T cell-mediated anti-tumor immunity. Additionally, dual COX-2/soluble epoxide hydrolase (sEH) inhibitors, such as PTUPB, demonstrate enhanced anti-tumor activity and reduced toxicity when combined with cisplatin, offering a promising approach to mitigate gastrointestinal side effects of nonsteroidal anti-inflammatory drugs (NSAIDs). Furthermore, natural products like ginsenoside Rk3 and berberine have been identified to regulate AA metabolism and gut microbiota, alleviating CAC by modulating lipid peroxidation and inflammatory pathways. This review synthesizes these innovative findings, highlighting the role of AA metabolism in maintaining intestinal homeostasis, promoting inflammatory cancer transformation, and serving as a therapeutic target to inhibit CAC progression, thus providing new insights into its prevention and treatment.

Subjects

Author keywords

arachidonic acidcancer therapycolorectal cancergut microbiotainflammatory cancer transformation

Authors and institutions

  • Institute of Digestive Diseases, Longhua Hospital, China-Canada Center of Research for Digestive Diseases (ccCRDD), Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
  • State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
  • Shanghai Frontier Research Center of Disease and Syndrome Biology of Inflammatory Cancer Transformation, Shanghai, 200032, China.

Cite

APA

Ren, S., Lu, L., Su, H., Li, Z., Li, S., Pan, J., Liu, Y., Ji, G., & Xu, H. (2025). Regulating arachidonic acid metabolism: a novel strategy to prevent colorectal inflammatory cancer transformation. Journal of Cancer, 16(14), 4155-4171. https://doi.org/10.7150/jca.118694

Vancouver

Ren S, Lu L, Su H, Li Z, Li S, Pan J, et al. Regulating arachidonic acid metabolism: a novel strategy to prevent colorectal inflammatory cancer transformation. Journal of Cancer. 2025;16(14):4155-4171. doi:10.7150/jca.118694

BibTeX
@article{Ren2025,
  author = {Ren, Sisi and Lu, Lu and Su, Hang and Li, Zongping and Li, Sumei and Pan, Jiashu and Liu, Yujing and Ji, Guang and Xu, Hanchen},
  title = {Regulating arachidonic acid metabolism: a novel strategy to prevent colorectal inflammatory cancer transformation},
  journal = {Journal of Cancer},
  year = {2025},
  volume = {16},
  number = {14},
  pages = {4155--4171},
  doi = {10.7150/jca.118694}
}
Start for free →